Literature DB >> 14206272

THE DEMONSTRATION OF THE SITE OF ACTION OF THE ANTIMETABOLITE DRUG 6-AZAURIDINE BY THE USE OF LEUCOCYTE CULTURES.

A S BUTTOO, M W ELVES, M C ISRAUELS, O S ROATH.   

Abstract

The ability of the lymphocyte cultured in vitro to transform and synthesize deoxyribonucleic has been utilized to locate the site of action of a new antimetabolite 6-azauridine which acts by inhibiting nucleic acid synthesis. The exact site can be demonstrated by incorporating into the cultures nucleotides occurring distal and proximal to the presumed site of action of 6-azauridine.

Entities:  

Keywords:  ANTIMETABOLITES; DNA; EXPERIMENTAL LAB STUDY; LEUKOCYTES; METABOLISM; NUCLEIC ACIDS; OROTIC ACID; PHARMACOLOGY; PYRIMIDINES; URACIL NUCLEOTIDES

Mesh:

Substances:

Year:  1964        PMID: 14206272      PMCID: PMC1703961          DOI: 10.1111/j.1476-5381.1964.tb01569.x

Source DB:  PubMed          Journal:  Br J Pharmacol Chemother        ISSN: 0366-0826


  6 in total

1.  A synopsis of recent investigations of 6-azauridine (NSC-32074).

Authors:  A D WELCH; R E HANDSCHUMACHER; S C FINCH; J J JAFFE; S S CARDOSO; P CALABRESI
Journal:  Cancer Chemother Rep       Date:  1960-11

2.  The chromosome constitution of a human phenotypic intersex.

Authors:  D A HUNGERFORD; A J DONNELLY; P C NOWELL; S BECK
Journal:  Am J Hum Genet       Date:  1959-09       Impact factor: 11.025

3.  Orotidylic acid decarboxylase: inhibition studies with azauridine 5'-phosphate.

Authors:  R E HANDSCHUMACHER
Journal:  J Biol Chem       Date:  1960-10       Impact factor: 5.157

4.  Phytohemagglutinin: an initiator of mitosis in cultures of normal human leukocytes.

Authors:  P C NOWELL
Journal:  Cancer Res       Date:  1960-05       Impact factor: 12.701

5.  Uracil antagonism and inhibition of mammary adenocarcinoma 755.

Authors:  G B ELION; S BIEBER; H NATHAN; G H HITCHINGS
Journal:  Cancer Res       Date:  1958-08       Impact factor: 12.701

6.  The kinetics of cell proliferation in cultures of human peripheral blood.

Authors:  A A MACKINNEY; F STOHLMAN; G BRECHER
Journal:  Blood       Date:  1962-03       Impact factor: 22.113

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.